Kidney Disorders, Dialysis and Transplantation

Q1 — Sample Band 6 response (8 marks), annotated

Homeostasis is the maintenance of a stable internal environment within narrow physiological limits. Homeostatic failure occurs when these mechanisms can no longer maintain balance — ESRD represents a catastrophic example: when GFR falls below 15 mL/min, the kidneys can no longer regulate plasma osmolarity, electrolyte concentrations (Na&sup+;, K&sup+;), acid-base balance, or excrete nitrogenous wastes such as urea and creatinine. Toxic waste accumulates, K&sup+; rises toward lethal levels, and every organ system is affected. [1 — homeostatic failure defined and linked to ESRD]

Haemodialysis uses diffusion across a synthetic semi-permeable membrane to remove urea and excess electrolytes three times per week; transplantation replaces the failed organ with a functioning donor kidney, restoring continuous filtration, hormone production (erythropoietin, activated vitamin D) and acid-base regulation. [1 — mechanism contrast established]

The ANZDATA data in Stimulus A show a consistent survival advantage for transplantation across all age groups. For 18–44 year olds, five-year survival on haemodialysis is 72% versus 97% with a living-donor transplant — a 25 percentage point difference. For 45–64 year olds, the gap is 48% (haemodialysis) versus 91% (living-donor transplant) — a 43 percentage point difference. In every cell of the table, transplant outperforms dialysis. [1 — comparison criterion: survival rates, with data] Quality of life represents a second criterion: haemodialysis patients average 12 hours per week at a centre, experience post-dialysis fatigue, and must follow severe dietary restrictions; kidney transplant recipients, after recovery, generally live near-normal lifestyles. [1 — second criterion: quality of life] Effectiveness is a third criterion: dialysis is intermittent (waste accumulates between sessions) and cannot replicate hormonal functions; transplant is continuous and restores most kidney functions. [1 — third criterion: effectiveness/completeness]

Transplantation carries a specific immunological challenge: the recipient's immune system recognises the donor kidney's HLA (human leukocyte antigen) surface proteins as foreign. T-cell mediated rejection can destroy the graft within days to weeks (acute rejection) or slowly over months to years (chronic rejection). This is managed with lifelong immunosuppressant therapy — for example, tacrolimus suppresses T-cell activation by blocking calcineurin. The trade-off is increased susceptibility to infection and certain cancers due to reduced immune surveillance. [1 — immunological challenge + named drug + trade-off]

Stimulus B identifies a critical systemic barrier: organ shortage. With ~2,700 Australians waiting a median 3.5 years for a deceased-donor kidney, and fewer than 1 in 3 willing donors registered on the Donor Register, dialysis is not always a choice freely compared to transplantation — it is often the only available treatment while patients wait. Automatic opt-out legislation could expand the donor pool, but is not yet implemented nationally. [1 — Stimulus B barrier identified and discussed]

Evidence-based judgement: transplantation is the preferred treatment for eligible patients — younger age, good health, and a willing living donor represent the clearest case for transplant given the 97% five-year survival. However, dialysis remains appropriate long-term when: surgical risk is high (significant comorbidities), the patient is older or frail, no suitable donor is available, or the patient cannot tolerate immunosuppression. Dialysis is also the necessary bridge during the transplant wait. The best choice is patient-specific, not modality-universal. [1 — evidence-based judgement that rejects "transplant always better" and specifies conditions]

Marking criteria.

• 1 mark — Defines homeostatic failure correctly and links it to ESRD (inability to regulate osmolarity, electrolytes, waste removal).
• 1 mark — Contrasts the mechanism of haemodialysis (semi-permeable membrane, intermittent) with transplantation (continuous, restores hormonal functions).
• 1 mark — Uses Stimulus A data to compare survival rates, with specific percentage values cited.
• 1 mark — Compares on a second criterion (quality of life OR effectiveness), with evidence.
• 1 mark — Compares on a third criterion (cost, reversibility, OR availability).
• 1 mark — Explains HLA rejection mechanism and names at least one immunosuppressant drug (tacrolimus, mycophenolate, or prednisolone).
• 1 mark — Uses Stimulus B to identify and discuss the organ shortage as a systemic barrier to transplant access.
• 1 mark — Reaches an explicit, evidence-based evaluative judgement specifying conditions under which each modality is preferred; rejects blanket "one is always better" framing.

Q2 — Sample Band 6 response (7 marks)

The claim is substantially incorrect, with only one minor element defensible. [1 — evaluative judgement]

What is defensible: The claim correctly identifies that dialysis involves surgical risk (fistula creation for HD; catheter insertion for PD) and that transplantation requires lifelong medication. These are factual. [1 — correctly identifies the defensible elements]

What is incorrect:

• "Just an artificial kidney — completely replaces what a healthy kidney does." Dialysis replicates filtration only — it cannot replicate erythropoietin production (which stimulates red blood cell production), activated vitamin D synthesis, or provide as precise acid-base regulation as a functioning kidney. Dialysis patients typically require erythropoietin injections and vitamin D supplements separately, precisely because dialysis does not fully replace renal endocrine function. [1 — refutes "complete replacement"]
• "Homeostasis is fully maintained." Dialysis provides intermittent waste clearance only three times per week for haemodialysis — waste and electrolytes (including K&sup+;) accumulate between sessions. Plasma K&sup+; can reach dangerous levels before the next session, and dietary restrictions are mandatory. This is not "full maintenance" of homeostasis, which requires continuous regulation. [1 — refutes "fully maintained homeostasis"]
• "Most nephrologists now recommend dialysis as the better long-term option for all patients." This is directly contradicted by the ANZDATA survival data: five-year survival for transplant recipients (88–97%) substantially exceeds that for haemodialysis patients (48–72%) across both age groups. Clinical guidelines and nephrologist consensus identify transplantation as the preferred treatment for eligible patients. [1 — refutes the "nephrologists prefer dialysis" claim, using ANZDATA data]

Biologically accurate reformulation: Dialysis is a life-sustaining treatment that partially replaces kidney filtration but cannot replicate all renal functions — notably hormone production and continuous homeostatic regulation. Kidney transplantation restores more complete renal function and is associated with substantially better long-term patient survival and quality of life for eligible patients; however, organ shortage, surgical risk, and the need for lifelong immunosuppression mean dialysis remains the appropriate — and sometimes the only available — treatment for many patients. Treatment choice must be individualised based on patient age, health status, donor availability, and comorbidities. [1 — biologically accurate reformulation addressing all flawed claims]

Marking criteria.

• 1 mark — States an overall evaluative judgement (e.g. "substantially incorrect" or "contains significant errors").
• 1 mark — Correctly identifies the one or two defensible elements (surgical risk of transplant; lifelong medication are factual).
• 1 mark — Refutes "complete replacement" — names at least one kidney function dialysis cannot replicate (erythropoietin, vitamin D, or continuous acid-base regulation).
• 1 mark — Refutes "homeostasis fully maintained" — explains that dialysis is intermittent and waste accumulates between sessions.
• 1 mark — Refutes the "nephrologists prefer dialysis" claim using ANZDATA survival data with specific figures.
• 2 marks — Biologically accurate reformulation that: (1) correctly characterises dialysis as partial, not complete, replacement; (2) correctly characterises transplantation as preferred for eligible patients with conditions specified; (3) avoids a simplistic "transplant always wins" conclusion. Award 1 mark for a partial reformulation, 2 marks for a complete and accurate one.